0000899243-19-003312.txt : 20190212 0000899243-19-003312.hdr.sgml : 20190212 20190212165217 ACCESSION NUMBER: 0000899243-19-003312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190209 FILED AS OF DATE: 20190212 DATE AS OF CHANGE: 20190212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lowery Thomas J. CENTRAL INDEX KEY: 0001615632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 19591613 MAIL ADDRESS: STREET 1: T2 BIOSYSTEMS, INC. STREET 2: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-09 0 0001492674 T2 Biosystems, Inc. TTOO 0001615632 Lowery Thomas J. 101 HARTWELL AVE LEXINGTON MA 02421 0 1 0 0 Chief Scientific Officer Common Stock 2019-02-09 4 M 0 5834 A 72709 D Common Stock 2019-02-11 4 S 0 3005 3.36 D 69704 D Restricted Stock Units 2019-02-09 4 M 0 5834 0.00 A Common Stock 5834 5833 D Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2018. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.31 to $3.40. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On February 9, 2017 the reporting person was granted 17,500 RSU's that vested in three equal annual installments beginning on February 9, 2018. /s/ John Sprague, Attorney-in-fact 2019-02-12